Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

investors.pfizer.com

Pfizer Inc. Press Releases

Get the latest updates from Pfizer Inc. Press Releases directly as they happen.

Follow now 221 followers

Latest posts

Last updated 6 days ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

6 days ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

7 days ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

9 days ago

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

9 days ago

Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

about 1 month ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

about 1 month ago

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

about 2 months ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

about 2 months ago

Pfizer Declares First-Quarter 2026 Dividend

2 months ago

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

2 months ago

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

2 months ago

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

2 months ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now